Sort   by:  
 Page size 
UnknownLisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy.
Not available
S-EPMC6316708 | biostudies-literature
UnknownResponse to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDS.
Not available
S-EPMC11814532 | biostudies-literature
UnknownPulicaria incisa (Lam.) DC. as a Potential Source of Antioxidant, Antibacterial, and Anti-Enzymatic Bioactive Molecules: Phytochemical Constituents, In Vitro and In Silico Pharmacological Analysis.
Not available
S-EPMC10648406 | biostudies-literature
UnknownCOVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Not available
S-EPMC7837033 | biostudies-literature
UnknownOxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.
Not available
S-EPMC7349409 | biostudies-literature
UnknownDetermination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.
Not available
S-EPMC3284423 | biostudies-literature
UnknownA Nature-Inspired Nrf2 Activator Protects Retinal Explants from Oxidative Stress and Neurodegeneration.
Not available
S-EPMC8389314 | biostudies-literature
UnknownACE2: The Major Cell Entry Receptor for SARS-CoV-2.
Not available
S-EPMC7653219 | biostudies-literature
UnknownEvaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study.
Not available
S-EPMC3552937 | biostudies-literature
UnknownPreventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
Not available
S-EPMC8555172 | biostudies-literature
Sort   by:  
 Page size